List of participating centers, investigators and staff: Cincinnati Children's Hospital Medical Center, Cincinnati, OH: Jens Goebel; Cleveland Clinic, Cleveland, OH: Robert Fairchild, Richard Fatica, Stuart Flechner, David Goldfarb, Karen Keslar, Venkatesh Krishnamurthi, Saul Nurko, Emilio Poggio and Brian Stephany; Cornell University School of Medicine, New York, NY: M. Suthanthiran; Emory University Medical Center, Atlanta, GA: Robert Bray, Howie Gebel and Kenneth A. Newell; Egleston Children's Hospital of Emory University, Atlanta, GA: Barry L. Warshaw; Icahn School of Medicine at Mount Sinai, New York, NY: Enver Akalin, Scott Ames, Jonathan Bromberg, Graciela DeBoccardo, Rajani Dinavahi, Peter S. Heeger, Susan Lerner, Marvin Lin, Barbara Murphy, Vinay Nair, Denise Peace, Bernd Schroppel and Vinita Seghal; Transplantation Branch, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD: Nancy D. Bridges and Yvonne Morrison; Rho, Chapel Hill, NC: David Ikle, Alexander Lockhardt, Katie Poole and Michael Riggs; University Hospitals Case Medical Center, Cleveland, OH: Mark Aeder, Joshua Augustine, Donald Hricik, Aparna Padiyar and James Schulak; University of Utah School of Medicine, Salt Lake City, UT: Fuad Shihab; University of Manitoba, Winnipeg, Manitoba, Canada: Patricia Birk, Ian Gibson, Peter Nickerson and David Rush; Yale University School of Medicine, New Haven, CT: Richard Formica and Danielle Jacques.
Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
Article first published online: 22 AUG 2013
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 10, pages 2634–2644, October 2013
How to Cite
Hricik, D. E., Nickerson, P., Formica, R. N., Poggio, E. D., Rush, D., Newell, K. A., Goebel, J., Gibson, I. W., Fairchild, R. L., Riggs, M., Spain, K., Ikle, D., Bridges, N. D., Heeger, P. S. and for the CTOT-01 consortium (2013), Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury. American Journal of Transplantation, 13: 2634–2644. doi: 10.1111/ajt.12426
- Issue published online: 24 SEP 2013
- Article first published online: 22 AUG 2013
- Manuscript Accepted: 11 MAY 2013
- Manuscript Revised: 3 MAY 2013
- Manuscript Received: 11 MAR 2013
- National Institutes of Health. Grant Number: AI63594-06
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.